United States Nanobodies Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
United States Nanobodies Market is Segmented By Product Type (Monovalent Nanobodies, Bivalent Nanobodies, Bispecific Nanobodies, Biparatopic Nanobodies, Multivalent Nanobodies, Fusion Nanobodies), By Therapeutic Area (Oncology, Infectious Diseases, Inflammatory and Autoimmune Diseases, Neurological Disorders, Others). The report offers the value (in USD Million) for the above-mentioned segments
Competitive overview of United States Nanobodies Market
The major players operating in the United States Nanobodies Market include Merck KGaA, Sanofi, GenScript, Numab Therapeutics, CUSABIO TECHNOLOGY LLC, Proteintech Group, Inc., GT Biopharma, Inc., Confo Therapeutics, QVQ, and MoonLake.
United States Nanobodies Market Leaders
- Merck KGaA
- Sanofi
- GenScript
- Numab Therapeutics
- CUSABIO TECHNOLOGY LLC
*Disclaimer: Major players are listed in no particular order.
United States Nanobodies Market - Competitive Rivalry, 2023
United States Nanobodies Market
Market Consolidated
(Dominated by major players)
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
(Highly competitive with lots of players.)
*Source: Coherent Market Insights